Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Henggliflozin vs liraglutide in overweight/obese type 2 diabetes with poor glycemic control
ChiCTR2400081365Phase 4Not yet recruiting
- Sponsor
- Shaanxi Provincial People's Hospital
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of henagliflozin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Shaanxi Provincial People's Hospital. Primary endpoint: Human body composition. Planned start Feb 2024; status: not yet recruiting.
02
Drugs
henagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR2400081365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400081365.